Brokerages Set BeiGene, Ltd. (NASDAQ:BGNE) PT at $278.43
BeiGene, Ltd. (NASDAQ:BGNE – Get Free Report) has been given an average rating of “Moderate Buy” by the nine brokerages that are covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month target price among brokers […]